Search for Clinical Trial Results
Albuminuria - 123 Studies Found
Status | Study |
Recruiting |
Study Name: Does Micro-albuminuria is a Predictive Factor for Cognitive Impairment in Persons Living With HIV (PLHIV) Who Achieve cART-sustained Immunovirological Control ? Condition: HIV Date: 2016-07-26 Interventions: Behavioral: Cognitive function tests |
Completed |
Study Name: Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria Condition: Hypertension Date: 2016-06-17 Interventions: Drug: CS-3150 CS-3150 1.25 to 2.5, 5mg, orally |
Completed |
Study Name: TELMA - Observational Study in Daily Medical Practice of the Effectiveness of Telmisartan for Treatment of Hypertension in Patients With and Without Confirmed Albuminuria in Belgium Condition: Hypertension Date: 2009-04-21 |
Not yet recruiting |
Study Name: GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes Condition:
Date: 2017-01-20 Interventions:
|
Completed |
Study Name: 6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria Condition: Diabetic Nephropathy Date: 2006-01-20 Interventions:
|
Terminated |
Study Name: To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy Condition: Non-diabetic Nephropathy Date: 2011-02-09 Interventions:
|
Enrolling by invitation |
Study Name: Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease Condition:
Date: 2012-11-09 Interventions:
|
Completed |
Study Name: Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria Condition: Type 2 Diabetes Mellitus With Diabetic Nephropathy Date: 2013-06-18 Interventions:
|
Active, not recruiting |
Study Name: Accuracy of Glomerular Filtration Rate (GFR) Estimation Using Creatinine and Cystatin C and Albuminuria Condition: Chronic Kidney Diseases Date: 2015-04-15 |
Recruiting |
Study Name: Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects Condition: Focal Segmental Glomerulosclerosis Date: 2015-10-22 Interventions: Drug: Dapagliflozin Oral tablet, 10mg, PO, 8 weeks O |